These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35210140)

  • 1. Human cadaver model as a training tool for enzymatic burn debridement (Nexobrid®): A feasibility study.
    Wen J; Johnson K; O'Boyle CP
    Burns; 2022 Nov; 48(7):1706-1709. PubMed ID: 35210140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial profile of burn wounds managed with enzymatic debridement using bromelain-based agent, NexoBrid®.
    Sharaf A; Muthayya P
    Burns; 2022 Nov; 48(7):1618-1625. PubMed ID: 34973852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eschar removal by bromelain based enzymatic debridement (Nexobrid
    Hirche C; Citterio A; Hoeksema H; Koller J; Lehner M; Martinez JR; Monstrey S; Murray A; Plock JA; Sander F; Schulz A; Ziegler B; Kneser U
    Burns; 2017 Dec; 43(8):1640-1653. PubMed ID: 29033046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Bromelain Activity During Enzymatic Debridement of Burn Wounds Pretreated With Frequently Used Products.
    Schulz A; Fuchs PC; Hans N; Opländer C; Valdez LB; Schiefer JL
    J Burn Care Res; 2018 Apr; 39(3):413-422. PubMed ID: 29897542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helpful hints in deciding what and when to operate after enzymatic debridement.
    Claes KEY; De Decker I; Monstrey S; Shoham Y; Vyncke T; Depypere B; De Wolf E; Decuypere F; Lannau B; Hoeksema H
    Burns; 2023 Feb; 49(1):80-90. PubMed ID: 35177282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Overview of the Use of Bromelain-Based Enzymatic Debridement (Nexobrid®) in Deep Partial and Full Thickness Burns: Appraising the Evidence.
    Loo YL; Goh BKL; Jeffery S
    J Burn Care Res; 2018 Oct; 39(6):932-938. PubMed ID: 29579268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromelain-based enzymatic burn debridement: A systematic review of clinical studies on patient safety, efficacy and long-term outcomes.
    Shoham Y; Gasteratos K; Singer AJ; Krieger Y; Silberstein E; Goverman J
    Int Wound J; 2023 Dec; 20(10):4364-4383. PubMed ID: 37455553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Retrospective Review of an Off-label Bromelain-based Selective Enzymatic Debridement (Nexobrid®) in the Treatment of Deep, Partial, and Full Thickness Burns and Hard to Heal Wounds.
    Harats M; Haik J; Cleary M; Vashurin I; Aviv U; Kornhaber R
    Isr Med Assoc J; 2020 Feb; 22(2):83-88. PubMed ID: 32043324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromelain-based enzymatic debridement of e-cigarette burns: a single unit experience.
    Ho W; Jones CD; Widdowson D; Bahia H
    J Wound Care; 2019 Nov; 28(11):758-761. PubMed ID: 31721672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Our initial learning curve in the enzymatic debridement of severely burned hands-Management and pit falls of initial treatments and our development of a post debridement wound treatment algorithm.
    Schulz A; Perbix W; Shoham Y; Daali S; Charalampaki C; Fuchs PC; Schiefer J
    Burns; 2017 Mar; 43(2):326-336. PubMed ID: 28341257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic debridement of hands with deep burns: a single center experience in the treatment of 52 hands.
    Dadras M; Wagner JM; Wallner C; Sogorski A; Sacher M; Harati K; Lehnhardt M; Behr B
    J Plast Surg Hand Surg; 2020 Aug; 54(4):220-224. PubMed ID: 32315252
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid and selective enzymatic debridement of porcine comb burns with bromelain-derived Debrase: acute-phase preservation of noninjured tissue and zone of stasis.
    Singer AJ; McClain SA; Taira BR; Rooney J; Steinhauff N; Rosenberg L
    J Burn Care Res; 2010; 31(2):304-9. PubMed ID: 20182376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic debridement in critically injured burn patients - Our experience in the intensive care setting and during burn resuscitation.
    Bowers C; Randawa A; Sloan B; Anwar U; Phipps A; Muthayya P
    Burns; 2022 Jun; 48(4):846-859. PubMed ID: 34493422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and safety of enzymatic debridement for the prevention of operative escharotomy in circumferential deep burns of the distal upper extremity.
    Fischer S; Haug V; Diehm Y; Rhodius P; Cordts T; Schmidt VJ; Kotsougiani D; Horter J; Kneser U; Hirche C
    Surgery; 2019 Jun; 165(6):1100-1105. PubMed ID: 30678870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic debridement for circumferential deep burns: the role of surgical escharotomy.
    Grünherz L; Michienzi R; Schaller C; Rittirsch D; Uyulmaz S; Kim BS; Giovanoli P; Lindenblatt N
    Burns; 2023 Mar; 49(2):304-309. PubMed ID: 36604280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Value of Debriding Enzymes as an Adjunct to Standard Early Surgical Excision in Human Burns: A Systematic Review.
    Salehi SH; Momeni M; Vahdani M; Moradi M
    J Burn Care Res; 2020 Nov; 41(6):1224-1230. PubMed ID: 32424404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of enzymatic debridement of deeply burned hands.
    Krieger Y; Bogdanov-Berezovsky A; Gurfinkel R; Silberstein E; Sagi A; Rosenberg L
    Burns; 2012 Feb; 38(1):108-12. PubMed ID: 22103988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic Versus Traditional Surgical Debridement of Severely Burned Hands: A Comparison of Selectivity, Efficacy, Healing Time, and Three-Month Scar Quality.
    Schulz A; Shoham Y; Rosenberg L; Rothermund I; Perbix W; Christian Fuchs P; Lipensky A; Schiefer JL
    J Burn Care Res; 2017; 38(4):e745-e755. PubMed ID: 28644207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Instantaneous Specific Burn Debridement With an Enzymatic Debriding Agent: A New Resource for the Treatment of Burns.
    Salmerón-González E; García-Vilariño E; Pérez-Del-Caz MD; Sánchez-García A; Valverde-Navarro AA
    Plast Surg Nurs; 2019; 39(1):18-21. PubMed ID: 30801494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update.
    Hirche C; Kreken Almeland S; Dheansa B; Fuchs P; Governa M; Hoeksema H; Korzeniowski T; Lumenta DB; Marinescu S; Martinez-Mendez JR; Plock JA; Sander F; Ziegler B; Kneser U
    Burns; 2020 Jun; 46(4):782-796. PubMed ID: 32241591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.